Skip to main content
Akela Pharma Inc. logo

Akela Pharma Inc. — Investor Relations & Filings

ISIN · CA00972X2005 TSX Professional, scientific and technical activities
Filings indexed 0 across all filing types
Latest filing no filings yet
Country CA Canada
Listing TSX

About Akela Pharma Inc.

http://www.akelapharma.com

Akela Pharma Inc. is an integrated drug development company focused on creating therapeutics for the pain and inhalation markets. The company leverages proprietary drug delivery technologies to develop pharmaceutical preparations targeting disorders of the respiratory and central nervous systems. A significant operational component is PharmaForm, a wholly owned subsidiary. PharmaForm functions as a specialty contract service provider, offering comprehensive expertise in pharmaceutical dosage form development, formulation research and development, and related pre-clinical and clinical services. Key historical developments include the licensing of the Fentanyl TAIFUN(R) system. The company has strategically prioritized its profitable contract services division.

Recent filings

No filings indexed yet

We are still gathering filings for Akela Pharma Inc.. .

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.